In resarch released some years ago, Serum levels of TBARS were strongly predictive of cardiovascular events in patients with stable CAD, independently of traditional risk factors and inflammatory markers. See: http://www.ncbi.nlm.nih.gov/pubmed/15542282
This means that Protandim proven to reduce TBARS, could be a very strong preventative measure against heart disease. This echo’s findings from the American Heart Association’s published article on Protandim back in 2009.
Is TBARS a valid measurement of oxidative stress? Yes. And it speaks volumes to the clinical effects of what Protandim can do.